Coherus oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer. Feb 23, 2026coherus is headquartered in the heart of california’s silicon valley and comprised of a team of industry veterans with decades of experience in developing and commercializing oncology. Check out the drug pipeline for coherus oncology, a commercial-stage company advancing next-generation combination therapies for people living with cancer.
Feb 4, 2026coherus oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation pd-1 inhibitor, loqtorzi ® (toripalimab-tpzi), and a pipeline that. View the portfolio of fda-approved medicines from coherus oncology, a commercial-stage company advancing next-generation combination therapies for cancer. Coherus oncology is a commercial-stage biopharma advancing next-generation combination therapies to elevate what’s possible for people living with cancer.
Dec 26, 2023coherus’ immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust. Jan 5, 2026press releases for coherus oncology, a commercial-stage biopharmacetucial company developing a pipeline of novel immuno-oncology therapies. Feb 13, 2026sec filings for coherus oncology, a commercial-stage biopharmacetucial company developing a pipeline of novel immuno-oncology therapies.
Meet the leadership of coherus oncology, a commercial-stage company advancing next-generation combination therapies for people living with cancer.
